Crestor Advisory Committee For Primary Prevention Of CV Disease To Focus On Adverse Events

AstraZeneca's JUPITER study could be added to the statin's label if advisory committee is not troubled by signals of gastrointestinal disorders, "confusional state" and diabetes.